NFKB1 and acute lymphoblastic leukemia: In 2021, a study by Lin et al. revealed that IRAK1 enhances the expression of both MMP-2 and MMP-9 in T-cell acute lymphoblastic leukemia (T-ALL) through the activation of NF-κB, specifically NF-κB p65 activity [80].